Klinik Königsfeld der DRV
Ennepetal, North Rhine-Westphalia, 58256, Germany
NCT Number: NCT03767088
Based on various studies, scientific evidence has proven the effectiveness of whole-body electromyostimulation (WB-EMS) on parameters such as increased physiological performance and body composition.
As a pilot project, the aim of the study is to determine the effect of additional WB-EMS as part of the inpatient four-week rehabilitation of sarcopenic subjects.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Ennepetal, North Rhine-Westphalia, 58256, Germany
The loss of muscle mass in the age-associated process (sarcopenia) is a common indication in the field of orthopedic and cardiac rehabilitation, which may also be reinforced by previous immobilization and disuse of the muscles (atrophy of muscle). Sarcopenia is defined as 2 standard deviations of average of the same sex in middle adult life. The present project focuses on the sarcopenia definition of the Foundation for the National Institutes of Health (FNIH). Their limits are < 0.789 (men) and < 0.512 (women) and are calculated by adding the absolute muscle mass of the extremities divided by the body mass index (BMI).
Due to reduced muscle mass and thus limited strength / performance, the implementation of conventional training tools with regard to generate corresponding intensities is no longer possible, or in persons with additional cardiac or orthopedic restrictions heavily limited.
In view of the existing indications, the alternative training technology whole-body electromyostimulation (WB-EMS) is an adequate training tool for the rehabilitation process. The time-saving (max 20 minutes per training session) and effective training method is characterized by low orthopedic and cardiac stress. Thus, WB-EMS combines both relevant aspects of a joint-friendly training with effects on muscle mass and functionality. Through the simultaneous activation of up to 10 muscle regions with corresponding, subjectively decidedly adjustable intensity per muscle group, up to 2,800 cm2 can be addressed. Synchronized to a motion video, the participants perform light physical exercises in parallel to the current pulses.
The aim of the study is, to evaluate the effect of additional WB-EMS during a 4-week period of inpatient rehabilitation, comparing 3 groups:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
whole body electromyostimulation
20 min of pronounced eccentric movement patterns
Time frame: 4 weeks
isometric strength [Nm] (DIERs Myoline professional, DIERs International GmbH)
Time frame: 4 weeks
chair rise test [repetitions; n]
Time frame: 4 weeks
6 minute walking test [distance; m]
Time frame: 4 weeks
via multifrequency bioimpedance analysis (BIA, Inbody770, Seoul, Korea)
Time frame: 4 weeks
via multifrequency bioimpedance analysis (BIA, Inbody770, Seoul, Korea)
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
blood-sample
Time frame: 4 weeks
questionnaire: Short Form 36 Health Survey (SF-36)
Time frame: 4 weeks
questionnaire: Allgemeine Selbstwirksamkeit Kurzskala (ASKU)
Time frame: 4 weeks
questionnaire: Late-Life Function & Disability Instrument (LLFDI)
Prof. Dr. Frank Mooren
Other
Evaluation of Whole-body Electromyostimulation (WB-EMS) in the Context of Inpatient Rehabilitation of Cardiological and Orthopedic Patients by Randomized Controlled Trial
Acronym: GERKO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07580144
Atrophy, Frailty
Konya, Turkey (Türkiye)
View Trial DetailsNCT06629805
Atrophy, Muscular Atrophy
Yangsan, South Korea
View Trial DetailsNCT07629063
Atrophy, Basal Ganglia Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07716839
Aging, Atrophy
Montes Claros, Minas Gerais, Brazil
View Trial Details